By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Astellas Pharma US 

1 Astellas Way

Northbrook  Illinois  60062  U.S.A.
Phone: 800-695-4321 Fax: n/a




Company News
Astellas Pharma US Appoints Karl Uhlendorf As Communications And Advocacy Director 6/24/2014 8:21:23 AM
Astellas Pharma US Release: Enzalutamide Data, Including Additional Results From The PREVAIL Trial, To Be Presented At Upcoming American Society of Clinical Oncology Annual Meeting 5/15/2014 7:04:42 AM
Astellas Pharma US Promotes Jeffrey Bloss To SVP Of Medical Affairs For The Americas 4/16/2014 6:35:08 AM
Astellas Pharma US Announces European Regulatory Submission For XTANDI® (enzalutamide) Capsules For Chemotherapy-Naive Metastatic Prostate Cancer 4/3/2014 9:23:22 AM
Astellas Pharma US Secures Exclusive Rights To Commercialize Isavuconazole In The U.S. And Canada 2/28/2014 10:58:47 AM
Astellas Pharma US To Present At J.P. Morgan Healthcare Conference 1/7/2014 8:01:30 AM
Astellas Pharma US And Vical Incorporated (VICL) Announce Initiation Of Phase 2 Trial Of ASP0113, A Cytomegalovirus Vaccine, In Solid Organ Transplant Recipients 12/10/2013 11:07:28 AM
FDA Grants Astellas Pharma US Qualified Infectious Disease Product Designation For Isavuconazole For The Treatment Of Invasive Aspergillosis 12/3/2013 11:26:40 AM
Astellas Pharma US Appoints Senior Vice President, Chief Communications Officer 10/30/2013 7:40:26 AM
National Institute for Clinical Excellence (NICE) Draft "Yes" for Astellas Pharma Inc. (ALPMY)' Prostate Cancer Drug 10/18/2013 8:12:40 AM